These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12361888)

  • 1. Estrogen therapy for prevention and treatment of osteoporosis.
    Dören M
    Maturitas; 2002 Aug; 43 Suppl 1():S53-6. PubMed ID: 12361888
    [No Abstract]   [Full Text] [Related]  

  • 2. Do estrogens effectively prevent osteoporosis-related fractures? The Group for the Respect of Ethics and Excellence in Science.
    Reginster JY; Bruyere O; Audran M; Avouac B; Body JJ; Bouvenot G; Brandi ML; Gennari C; Kaufman JM; Lemmel EM; Vanhaelst L; Weryha G; Devogelaer JP
    Calcif Tissue Int; 2000 Sep; 67(3):191-4. PubMed ID: 10954771
    [No Abstract]   [Full Text] [Related]  

  • 3. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.
    O'Connell D; Robertson J; Henry D; Gillespie W
    Climacteric; 1998 Jun; 1(2):112-23. PubMed ID: 11907914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY
    Clin Evid; 2002 Jun; (7):979-82. PubMed ID: 12230720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of osteoporosis: estrogen substitution paradigm].
    Lange S; Paesler E; Richter K
    Gesundheitswesen; 1996 Feb; 58(2):111-4. PubMed ID: 8881083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates in the treatment of osteoporosis. Principles and efficacy.
    Papapoulos SE
    Ann Med Interne (Paris); 2000 Oct; 151(6):504-10. PubMed ID: 11104931
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteoporosis. Fracture as alarm signal].
    MMW Fortschr Med; 2001 Oct; 143(41):56. PubMed ID: 11721665
    [No Abstract]   [Full Text] [Related]  

  • 9. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone therapy to prevent hip fractures in elderly.
    Brzezny AL
    Am Fam Physician; 2003 Oct; 68(8):1489; author reply 1489-90. PubMed ID: 14596436
    [No Abstract]   [Full Text] [Related]  

  • 11. Strategies for prevention of osteoporosis and hip fracture.
    Law MR; Wald NJ; Meade TW
    BMJ; 1991 Aug; 303(6800):453-9. PubMed ID: 1912840
    [No Abstract]   [Full Text] [Related]  

  • 12. Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
    Adachi JD
    Can Fam Physician; 1998 Feb; 44():327-32. PubMed ID: 9512836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fracture prevention in postmenopausal women.
    Bruyere O; Edwards J; Reginster JY
    Clin Evid; 2003 Jun; (9):1186-202. PubMed ID: 12967416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of hip fractures in the elderly: where are we in 2003?].
    Reginster JY; Lecart MP; Sarlet N; Halkin V
    Rev Med Liege; 2003 Apr; 58(4):183-90. PubMed ID: 12875249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY; Edwards J
    Clin Evid; 2002 Dec; (8):1089-102. PubMed ID: 12603931
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
    Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
    Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of osteoporosis with parathyroid hormone: evidence and perspective].
    Kaji H; Sugimoto T
    Clin Calcium; 2005 Apr; 15(4):611-5. PubMed ID: 15802773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.
    Jansen JP; Bergman GJ; Huels J; Olson M
    Semin Arthritis Rheum; 2011 Feb; 40(4):275-84.e1-2. PubMed ID: 20828791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene and prevention of vertebral fracture (cont'd): mainly when oestrogen is contraindicated.
    Prescrire Int; 2000 Dec; 9(50):190-1. PubMed ID: 11475503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risedronate treatment and extended fracture protection in postmenopausal women.
    Harris ST
    Clin Exp Rheumatol; 2001; 19(6):625-6. PubMed ID: 11791630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.